Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-24 @ 11:39 PM
NCT ID:
NCT03363451
Eligibility Criteria:
Inclusion Criteria:
Decompensation of liver cirrhosis:
1. ALB \<35 g / L; A / G \<1.0
2. TBIL\> 35μmol / L;
3. ALT\> 1 × ULN and / or AST\> 1 × ULN
4. PTA \<60%
5. Ascites or hepatic encephalopathy or esophageal variceal bleeding
Acute-on-chronic liver failure:
1. Chronic liver disease based on: chronic hepatitis or decompensated cirrhosis
2. onset time: \<4 weeks
3. Hepatic encephalopathy: with or without
4. Coagulation: PTA ≤ 40% or INR ≥ 1.5
5. Jaundice: TBIL ≥ 171μmol / L or daily increase ≥ 17.1μmol / L
Chronic liver failure:
1. The basis of chronic liver disease: decompensated cirrhosis
2. onset time: -
3. Hepatic encephalopathy: with or without
4. Coagulation: PTA ≤ 40% or INR ≥ 1.5 Jaundice: significantly higher
Exclusion Criteria:
\-
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03363451
Study Brief:
Protocol Section:
NCT03363451